Clinical trials
Phase 1/2 Carcinoma, Renal Cell trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Fred Hutchinson Cancer Center | 2 |
| Mologen AG | 1 |
| Nykode Therapeutics ASA | 1 |
| Pfizer | 1 |
| Philogen S.p.A. | 1 |
| University of Magdeburg | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 9 |
| Anemia, Refractory | 2 |
| Hodgkin Disease | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Melanoma | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Burkitt Lymphoma | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.